Soligenix, Inc. Gains 25.96%
Tue, Jul 06, 2021 at 05:30 PM
Soligenix, Inc. (SNGX:NASDAQ) rocketted at $1.31, a gain of 26%. On Fri, Jul 02, 2021, SNGX:NASDAQ touched a New 2-Week Low of $1.04. The stock appeared on our News Catalysts scanner on Wed, Jun 23, 2021 at 10:36 AM in the 'MISCELLANEOUS' category. From Fri, Jun 18, 2021, the stock recorded 30.00% Up Days and 27.27% Green Days
The stock spiked on Thu, Jun 10, 2021 at $1.34 with a volume of 4M+, and its share price has been moving sideways in recent weeks.
About Soligenix, Inc. (SNGX:NASDAQ)
Soligenix Inc is a clinical stage biopharmaceutical company focused on focused on developing and commercializing products to treat rare diseases where there is an unmet medical need.
Top 10 Gainers:
- BSQUARE Corporation (BSQR:NASDAQ), 77.14%
- Powerbridge Technologies Co., Ltd. (PBTS:NASDAQ), 69.44%
- PFSweb, Inc. (PFSW:NASDAQ), 42.67%
- Exela Technologies, Inc. (XELA:NASDAQ), 42.55%
- NEGG (NEGG:NASDAQ), 41.67%
- Bridgeline Digital, Inc. (BLIN:NASDAQ), 36.34%
- BON (BON:NASDAQ), 26.46%
- Soligenix, Inc. (SNGX:NASDAQ), 25.96%
- Advaxis, Inc. (ADXS:NASDAQ), 23.31%
- GasLog Partners LP (GLOP:NYSE), 22.98%